IRIX Form 4: CFO Romeo Dizon Adds 1,000 Shares to 49,745-Share Stake
Rhea-AI Filing Summary
Iridex Corp Chief Financial Officer Romeo R. Dizon reported purchases of common stock on 08/26/2025. The filing shows two open-market buys: 750 shares at $1.26 and 250 shares at $1.25, for a total of 1,000 shares acquired. Following these transactions his beneficial ownership increased to 49,745 shares. The Form 4 was signed by an attorney-in-fact on 08/27/2025 and contains no derivative transactions or additional explanatory notes.
Positive
- None.
Negative
- None.
Insights
TL;DR: CFO Romeo Dizon purchased 1,000 IRIX shares in two transactions, modestly increasing his stake to 49,745 shares.
These are straightforward, small open-market purchases reported on a Form 4. The transactions total 1,000 shares at prices of $1.26 and $1.25, respectively, and there are no reported derivative positions or dispositions. For investors, this filing is a routine insider purchase disclosure rather than a material corporate event. It provides transparency on insider activity but does not, by itself, change the companys financial condition or capital structure.
TL;DR: Insider buying by a named executive; procedural filing signed by attorney-in-fact.
The Form 4 is properly completed: it identifies the reporting person, relationship to the issuer (CFO and director), the transaction dates, purchase codes, share amounts, and post-transaction holdings. The signature is by attorney-in-fact, dated 08/27/2025. No amendments or additional disclosures are present. From a governance perspective, the filing meets disclosure obligations and signals routine insider accumulation without accompanying commentary or plans.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 750 | $1.26 | $945.00 |
| Purchase | Common Stock | 250 | $1.25 | $312.50 |